Race against superbug: new antibiotic strategy tested in 5,000 patients
NCT ID NCT07226557
Summary
This study is comparing two different antibiotic treatment plans for a serious, drug-resistant bacterial infection called CRAB. It will look at data from about 5,000 hospitalized adults to see if a 7-day course of a newer antibiotic (cefiderocol) leads to better survival than 7 days of the current best available therapy. The main goal is to find out which approach helps more patients survive the first 28 days after treatment starts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL DRUG RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.